Search alternatives:
4 inhibitors » 2 inhibitors

21
by López, José I.
Published 2022
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1...

22
Published 2020
Springer International Publishing
Table of Contents: ... and Chemotherapeutic Agents -- Bleomycin -- BRAF Inhibitors (vemurafenib) -- Anti CTLA-4 -- Hand Foot Syndrome vs Hand...

23
by Fanti, Stefano
Published 2021
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1...

24
by Fanti, Stefano
Published 2021
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1...

25
by Zhou, Xuefeng
Published 2022
Subjects: ...PD-L1...

26
by Drašar, Pavel B.
Published 2022
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1...

27
by Szkandera, Joanna
Published 2023
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1...

28
by Luparello, Claudio
Published 2020
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-1 immune checkpoint inhibitor and cancer immunotherapy...

29
by Bousbaa, Hassan
Published 2023
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...anti-PD-L1...

30
by Caminade, Anne-Marie
Published 2023
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-(L)1 inhibitors...

31
by Alix-Panabieres, Catherine
Published 2020
MDPI - Multidisciplinary Digital Publishing Institute
Subjects: ...PD-L1 expression...

32
Published 2023
Springer Nature Singapore
Table of Contents: ... advances in the immunotherapy of Lung cancer -- Chapter 5_PD-1/PD-L1 inhibitors for the treatment of Lung...

33
Published 2023
Springer Nature Switzerland
Table of Contents: ... and Metastatic Nasopharyngeal Carcinoma -- Beyond PD-1/PD-L1 Immune Checkpoint Inhibitors: Other Targets...

34
Published 2019
Springer International Publishing
Table of Contents: ... Considerations with EGFR inhibitors in NSCLC -- Chapter 4. Nursing Considerations with ALK and ROS1 inhibitors...

35
Published 2020
Springer Nature Singapore
Table of Contents: ...Introduction -- Molecular and cellular functions of CTLA-4 pathway -- Roles of PD-1/PD-L1 pathway...

36
Published 2006
Springer Vienna
Table of Contents: ... of selenium, iron, copper and zinc in on/off Parkinson’s patients on L-dopa therapy -- Metal specificity...

37
Published 2012
Humana
Table of Contents: ...-PD-1 and Anti-B7-H1/PD-L1 monoclonal antibodies -- Treatment of melanoma with agonist immune co...

38
Published 2021
Springer Nature Singapore
Table of Contents: ... we treat the patients failed to PD-1/PD-L1 inhibitors? -- 23. Biomarkers for Immune checkpoint...

39
Published 1991
Springer US
Table of Contents: ... Comparison of Potential HIV Inhibitors: 2?,3?-Didesoxinucleosides and 2?,3?-Didesoxicarbonucleosides...